MURA
Price
$2.10
Change
+$0.01 (+0.48%)
Updated
Sep 25, 04:59 PM (EDT)
Capitalization
36.21M
47 days until earnings call
NUVB
Price
$3.01
Change
-$0.23 (-7.10%)
Updated
Sep 25 closing price
Capitalization
1.03B
40 days until earnings call
Interact to see
Advertisement

MURA vs NUVB

Header iconMURA vs NUVB Comparison
Open Charts MURA vs NUVBBanner chart's image
Mural Oncology
Price$2.10
Change+$0.01 (+0.48%)
Volume$399
Capitalization36.21M
Nuvation Bio
Price$3.01
Change-$0.23 (-7.10%)
Volume$7.08M
Capitalization1.03B
MURA vs NUVB Comparison Chart in %
Loading...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MURA vs. NUVB commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MURA is a Buy and NUVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (MURA: $2.09 vs. NUVB: $3.01)
Brand notoriety: MURA and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MURA: 50% vs. NUVB: 125%
Market capitalization -- MURA: $36.21M vs. NUVB: $1.03B
MURA [@Biotechnology] is valued at $36.21M. NUVB’s [@Biotechnology] market capitalization is $1.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MURA’s FA Score shows that 1 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • MURA’s FA Score: 1 green, 4 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVB is a better buy in the long-term than MURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MURA’s TA Score shows that 5 TA indicator(s) are bullish while NUVB’s TA Score has 4 bullish TA indicator(s).

  • MURA’s TA Score: 5 bullish, 1 bearish.
  • NUVB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MURA is a better buy in the short-term than NUVB.

Price Growth

MURA (@Biotechnology) experienced а +0.48% price change this week, while NUVB (@Biotechnology) price change was -5.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

MURA is expected to report earnings on Nov 12, 2025.

NUVB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.03B) has a higher market cap than MURA($36.2M). NUVB YTD gains are higher at: 13.158 vs. MURA (-35.093). MURA has higher annual earnings (EBITDA): -131.93M vs. NUVB (-201.17M). NUVB has more cash in the bank: 608M vs. MURA (77.1M). MURA has less debt than NUVB: MURA (5.17M) vs NUVB (57.8M). NUVB has higher revenues than MURA: NUVB (14.4M) vs MURA (0).
MURANUVBMURA / NUVB
Capitalization36.2M1.03B4%
EBITDA-131.93M-201.17M66%
Gain YTD-35.09313.158-267%
P/E RatioN/AN/A-
Revenue014.4M-
Total Cash77.1M608M13%
Total Debt5.17M57.8M9%
TECHNICAL ANALYSIS
Technical Analysis
MURANUVB
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 7 days ago
80%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFALX33.09N/A
N/A
DFA Large Cap International I
RIGKX16.58N/A
N/A
Victory RS International R
EXTGX59.50N/A
N/A
Eaton Vance Tx-Mgd Growth 1.2 A
GSMVX16.98N/A
N/A
Goldman Sachs Small/Mid Cap Equity Instl
CAPOX10.55N/A
N/A
Absolute Capital Opportunities Instl

MURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MURA has been loosely correlated with CRMD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MURA jumps, then CRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MURA
1D Price
Change %
MURA100%
N/A
CRMD - MURA
37%
Loosely correlated
-1.07%
IPSC - MURA
33%
Poorly correlated
+0.66%
IRD - MURA
32%
Poorly correlated
+4.88%
NUVB - MURA
32%
Poorly correlated
-7.10%
GBIO - MURA
32%
Poorly correlated
-0.69%
More